NCT01007032View on ClinicalTrials.gov

A Study of IMC-A12 in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2015

Conditions
Tumors
Interventions
BIOLOGICAL

Cixutumumab

Cixutumumab intravenously

Trial Locations (1)

277 8577

ImClone Investigational Site, Kashiwa

Sponsors

Collaborators (2)

Parexel
Medidata Solutions
All Listed Sponsors
collaborator

Parexel

INDUSTRY

collaborator

Medidata Solutions

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY